shopping cart Your cart is empty
  • Home
  • Press Release
  • Growing Prevalence Of Cardiovascular Diseases Drives The Global Cardiac Equipment Technologies Market

Growing Prevalence Of Cardiovascular Diseases Drives The Global Cardiac Equipment Technologies Market

Jun 23, 2016

According to a recently published report, the global Cardiac Equipment Technologies Market is expected to grow at $71000 million till 2022 with the CAGR of 5.9% during 2016-2022. The segmentation of global cardiac equipment technologies market is based on end users, product type and regional outlook. The report on global cardiac equipment technologies market forecast 2016-2022 (end users, products type and regional outlook) provides a detailed overview and predictive analysis of the market.

Full report is available on global cardiac equipment technologies market forecast 2016-2022 (end users, products type and regional outlook) report at http://www.briskinsights.com/report/cardiac-equipment-technologies-market

Direct and indirect costs on cardiovascular and stroke diseases are more than $320.1 billion and this data is expected to grow even further in forecast year as there is a tremendous growth in cardiovascular diseases worldwide. Cardiovascular diseases like heart attack and strokes are one of the major causes of death worldwide. In United States it is the number the number one cause of death, killing around 800000 people alone. Cardiovascular diseases take more lives than all forms of cancer together combined. Coronary heart disease is one of the most common heart diseases. Cardiovascular diseases take around 17.6 million deaths per year and this data is expected to grow around 24 million in forecast year. The cardiovascular disease shares around 32% of global deaths. People suffering from diabetes, hypertension, and hyperlipidemia are likely to get cardiovascular diseases more often. Rising cardiac disease needs to be treated to reduce cardiac deaths. Cardiovascular diseases are majorly caused by lifestyle related issues, consumption of alcohol and cigarettes, obesity etc. Rising prevalence regarding cardiovascular diseases acts as a fueling agent in enhancing the global cardiac equipment technologies markets


Scope of the report

1. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET By End Users 2012 - 2022 ($ million)
1.1. Hospitals
1.2. Home/ ambulatory
1.3. Others

2. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET By Products Type 2012 - 2022 ($ million)
2.1. ECG
2.1.1. Resting ECG
2.1.2. Stress ECG
2.1.3. Holter Monitors
2.1.4. ECG by lead type
2.1.4.1. Single lead
2.1.4.2. 3-6 lead
2.1.4.3. 12 lead
2.2. Defibrillators
2.2.1. Implantable cardioverter defibrillators
2.2.2. External defibrillators
2.2.3. Pacemakers
2.2.4. Cardiac resynchronization therapy devices

3. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKETS Regional Outlook 2012-2022 ($ million)
3.1. North America
3.2. Europe
3.3. Asia Pacific
3.4. Rest of the world

4. Company profiles
4.1. ASAHI KASEI CORP.
4.2. BIOTRONIK SE & CO. KG
4.3. BOSTON SCIENTIFIC CORP.
4.4. CARDIAC SCIENCE CORP.
4.5. CARDICA INC.
4.6. CAREWELL HEALTHCARE
4.7. COHEREX MEDICAL INC.
4.8. CONTEC MEDICAL SYSTEMS CO. LTD.
4.9. COOK MEDICAL INC.
4.10. EBR SYSTEMS INC.
4.11. EDAN INSTRUMENTS INC.
4.12. HEARTSINE TECHNOLOGIES INC.
4.13. HEARTWARE INC.
4.14. IVY BIOMEDICAL SYSTEMS INC.
4.15. LIFEWATCH SERVICES INC.